Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans
New leaders to elevate product portfolio, customer-centric business capabilities, and sales and marketing execution SALT LAKE CITY, Dec. 19 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the arrival of five senior executives to help further strengthen the company product roadmap and improve …
Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans Read More »
